cucurbitacin r has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augenlicht, L; Escandell, JM; Kaler, P; Klampfer, L; Recio, MC; RĂos, JL; Sasazuki, T; Shirasawa, S | 1 |
1 other study(ies) available for cucurbitacin r and Colonic Neoplasms
Article | Year |
---|---|
Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Triterpenes; Tumor Suppressor Protein p53 | 2008 |